Premise: "FDA finds that the one-time cost of compliance for each product, estimated to be $600, should be manageable for small entities even if they manufacture 10 to 20 products that require relabeling at a cost of $6,000 to $12,000." If this premise is true, what does that tell us about whether it entails the hypothesis "Small entities should be able to afford a one-time cost of compliance."?
yes